Ceftriaxone
- Product NDC
- 70594-098
- 11-digit product format
- 705940098
- Labeler code
- 70594
- Product ID
- 70594-098_d4819f4d-0e62-4647-b642-2727358f8727
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ceftriaxone
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Xellia Pharmaceuticals USA LLC
- Application
- ANDA091117
- Marketing category
- ANDA
- Marketing start
- 2022-01-06
- Marketing end
- 0000-00-00
- Substance
- CEFTRIAXONE SODIUM
- Active strength
- 10 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70594-098 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [XELLIA PHARMACEUTICALS USA LLC] | 2 | Legacy NDC | 20241215_856be1ac-03a6-47be-b4a8-e9e8e7c87da5.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70594-098-01 | 70594009801 | 1 VIAL in 1 CARTON (70594-098-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | 1 vial | 2022-01-06 | 0000-00-00 | No | No | Current |